CD99 and neoplasm: Differential activity of CD99 in tumour cells and healthy primary leucocytes likely reflects the number and nature of the different cell surface molecules implicated in the adhesion/TEM pathways and the relative expression of these molecules by the migrating cell type (Muller, 2016).